Taiwan Liposome Ltd.

NASDAQ: TLC · Real-Time Price · USD
7.00
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Taiwan Liposome Income Statement

Financials in TWD. Fiscal year is January - December.
Fiscal Year Q2 2021 Q1 2021
Period Ending Jun 30, 2021 Mar 31, 2021
Revenue
160.18M 37.62M
Cost of Revenue
n/a n/a
Gross Profit
160.18M 37.62M
Operating Income
-91.53M -216.2M
Interest Income
n/a n/a
Pretax Income
-75.14M -218M
Net Income
-75.51M -201.37M
Selling & General & Admin
31.62M 31.05M
Research & Development
220.09M 222.77M
Other Expenses
n/a n/a
Operating Expenses
251.71M 253.82M
Interest Expense
n/a n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
251.71M 253.82M
Income Tax Expense
363K 239K
Shares Outstanding (Basic)
42.08M 42.13M
Shares Outstanding (Diluted)
42.08M 42.13M
EPS (Basic)
-1.79 -4.78
EPS (Diluted)
-1.79 -4.78
EBITDA
-75.14M -201.13M
EBIT
-91.53M -216.2M
Depreciation & Amortization
16.39M 15.07M